Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | GRFS |
---|---|---|
09:32 ET | 2583 | 9.09 |
09:34 ET | 1100 | 9.12 |
09:36 ET | 100 | 9.09 |
09:39 ET | 1662 | 9.07 |
09:41 ET | 1900 | 9.07 |
09:43 ET | 1450 | 9.06 |
09:45 ET | 970 | 9.045 |
09:48 ET | 622 | 9.02 |
09:50 ET | 815 | 8.98 |
09:52 ET | 907 | 8.975 |
09:54 ET | 1400 | 9 |
09:56 ET | 500 | 9 |
09:57 ET | 500 | 8.95 |
09:59 ET | 102 | 8.955 |
10:01 ET | 400 | 8.93 |
10:03 ET | 700 | 8.96 |
10:06 ET | 707 | 8.965 |
10:08 ET | 885 | 8.965 |
10:12 ET | 400 | 8.965 |
10:14 ET | 2013 | 8.9899 |
10:15 ET | 800 | 8.995 |
10:17 ET | 4826 | 8.985 |
10:19 ET | 1100 | 8.98 |
10:21 ET | 11269 | 8.998 |
10:24 ET | 600 | 8.995 |
10:26 ET | 804 | 8.995 |
10:28 ET | 12222 | 8.995 |
10:30 ET | 300 | 8.995 |
10:32 ET | 858 | 8.995 |
10:33 ET | 1200 | 8.99 |
10:35 ET | 1400 | 8.99 |
10:37 ET | 2500 | 8.9701 |
10:39 ET | 500 | 8.975 |
10:42 ET | 700 | 8.98 |
10:44 ET | 780 | 8.98 |
10:46 ET | 1301 | 8.995 |
10:48 ET | 1100 | 9.02 |
10:50 ET | 3704 | 9.01 |
10:51 ET | 205 | 9.015 |
10:53 ET | 300 | 9.005 |
10:55 ET | 1440 | 8.995 |
10:57 ET | 1700 | 9.005 |
11:00 ET | 700 | 8.985 |
11:02 ET | 1875 | 8.99 |
11:04 ET | 700 | 8.99 |
11:06 ET | 12974 | 9.03 |
11:08 ET | 1624 | 9.03 |
11:09 ET | 934 | 9.005 |
11:11 ET | 8645 | 9.06 |
11:13 ET | 2610 | 9.055 |
11:15 ET | 1800 | 9.045 |
11:18 ET | 5360 | 9.06 |
11:20 ET | 2900 | 9.07 |
11:22 ET | 1400 | 9.07 |
11:24 ET | 4130 | 9.08 |
11:26 ET | 6454 | 9.095 |
11:27 ET | 4702 | 9.095 |
11:29 ET | 4310 | 9.14 |
11:31 ET | 1270 | 9.125 |
11:33 ET | 1100 | 9.13 |
11:36 ET | 4000 | 9.12 |
11:38 ET | 402 | 9.125 |
11:40 ET | 1110 | 9.135 |
11:42 ET | 200 | 9.125 |
11:44 ET | 1201 | 9.095 |
11:45 ET | 1705 | 9.095 |
11:47 ET | 300 | 9.1 |
11:49 ET | 100 | 9.095 |
11:51 ET | 1206 | 9.085 |
11:54 ET | 1061 | 9.075 |
11:56 ET | 1498 | 9.075 |
11:58 ET | 200 | 9.07 |
12:00 ET | 2203 | 9.05 |
12:02 ET | 1219 | 9.05812 |
12:03 ET | 1921 | 9.065 |
12:05 ET | 460 | 9.055 |
12:07 ET | 300 | 9.06 |
12:09 ET | 900 | 9.05 |
12:12 ET | 2862 | 9.055 |
12:14 ET | 388 | 9.05 |
12:16 ET | 800 | 9.025 |
12:18 ET | 1100 | 9.0205 |
12:20 ET | 2818 | 9.035 |
12:21 ET | 350 | 9.0301 |
12:23 ET | 1600 | 9.04 |
12:25 ET | 400 | 9.035 |
12:27 ET | 920 | 9.045 |
12:30 ET | 100 | 9.04 |
12:32 ET | 2730 | 9.04 |
12:34 ET | 3947 | 9.045 |
12:36 ET | 1389 | 9.045 |
12:38 ET | 2549 | 9.095 |
12:39 ET | 3690 | 9.085 |
12:41 ET | 847 | 9.095 |
12:45 ET | 2043 | 9.1 |
12:48 ET | 100 | 9.09 |
12:50 ET | 200 | 9.08 |
12:52 ET | 654 | 9.08 |
12:54 ET | 1609 | 9.095 |
12:56 ET | 700 | 9.09 |
12:57 ET | 300 | 9.095 |
12:59 ET | 500 | 9.09 |
01:01 ET | 700 | 9.09 |
01:03 ET | 158 | 9.095 |
01:06 ET | 3095 | 9.105 |
01:08 ET | 200 | 9.09 |
01:10 ET | 900 | 9.095 |
01:12 ET | 100 | 9.09 |
01:14 ET | 100 | 9.09 |
01:15 ET | 6100 | 9.095 |
01:17 ET | 448 | 9.09 |
01:19 ET | 100 | 9.09 |
01:21 ET | 5521 | 9.105 |
01:24 ET | 1420 | 9.115 |
01:26 ET | 300 | 9.115 |
01:28 ET | 25714 | 9.1 |
01:30 ET | 1300 | 9.12 |
01:32 ET | 1874 | 9.105 |
01:33 ET | 1278 | 9.11 |
01:35 ET | 1500 | 9.13 |
01:37 ET | 400 | 9.115 |
01:39 ET | 400 | 9.115 |
01:42 ET | 200 | 9.115 |
01:44 ET | 100 | 9.115 |
01:46 ET | 1200 | 9.124 |
01:48 ET | 1349 | 9.125 |
01:51 ET | 100 | 9.115 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Grifols SA | 7.0B | 37.4x | --- |
ICON PLC | 24.0B | 34.8x | +4.68% |
Charles River Laboratories International Inc | 10.0B | 23.2x | +15.57% |
Moderna Inc | 30.6B | -4.6x | --- |
Biogen Inc | 29.0B | 24.8x | -18.14% |
Incyte Corp | 12.2B | 179.1x | +39.11% |
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.0B |
---|---|
Revenue (TTM) | $7.5B |
Shares Outstanding | 687.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.50 |
EPS | $0.24 |
Book Value | --- |
P/E Ratio | 37.4x |
Price/Sales (TTM) | 0.9 |
Price/Cash Flow (TTM) | 9.7x |
Operating Margin | 14.81% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.